(Q38098802)

28 August 2017

title

The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes (English)

1 reference

28 August 2017

1 reference

1 reference

Laura M Harrison

1

1 reference

28 August 2017

Gerald J Lahoste

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

10 April 2013

1 reference

Experimental Cell Research

28 August 2017

published in

1 reference

28 August 2017

volume

319

1 reference

28 August 2017

issue

15

1 reference

28 August 2017

page(s)

2310-2315

1 reference

Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Genes expressed in human tumor endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes expression in pancreatic beta-cells is regulated by efaroxan in a calcium-dependent process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes is involved in striatal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Regional specificity of brain atrophy in Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Mechanisms of neurodegeneration in Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

SUMO on the road to neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

A huntingtin-associated protein enriched in brain with implications for pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Enhanced SUMOylation in polyglutamine diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

SUMO modification of Huntingtin and Huntington's disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Increased frequency of diabetes mellitus in patients with Huntington's chorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Islet beta-cell area and hormone expression are unaltered in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes: a GTP-binding protein integral to striatal physiology and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

The monomeric G proteins AGS1 and Rhes selectively influence Galphai-dependent signaling to modulate N-type (CaV2.2) calcium channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Striatum specific protein, Rhes regulates AKT pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.03.033

10.1016/J.YEXCR.2013.03.033

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference